| Literature DB >> 35448066 |
Diana Sologova1, Ekaterina Diachkova1, Ilana Gor1, Susanna Sologova2, Ekaterina Grigorevskikh2, Liana Arazashvili3, Pavel Petruk3, Svetlana Tarasenko1.
Abstract
(1) Background: Antibiotics are used in every medical field including dentistry, where they are used for the prevention of postoperative complications in routine clinical practice during the third molar extraction. (2)Entities:
Keywords: antibiotic; extraction; prophylaxis; systematic review; third molar
Year: 2022 PMID: 35448066 PMCID: PMC9031928 DOI: 10.3390/dj10040072
Source DB: PubMed Journal: Dent J (Basel) ISSN: 2304-6767
Characteristics of included studies—randomized controlled trials.
| Author | Year | Type of Study | Sample Size | Protocols | Results |
|---|---|---|---|---|---|
| López-Cedrún et al. [ | 2011 | RCT | 123 | Preoperative amoxicillin (2 g AMX 2 h before surgery) vs. postoperative amoxicillin (15 tablets of amoxicillin 500 mg to be taken immediately after surgery 3 times daily for 5 days) vs. placebo (4 placebo tablets 2 h preoperatively and 15 tablets of placebo taken 3 times daily for 5 days) | Placebo group—5 socket infections and 1 suture dehiscence. No differences in side effects between the groups. |
| Siddiqi et al. [ | 2011 | RCT | 89 | Group 1—placebo; Group 2—amoxicillin 1 g 1 h before surgery; Group 3—metronidazole 800 mg 1 h before surgery | There was no difference in surgical wound infection between groups. |
| Sisalli et al. [ | 2012 | RCT | 107 | Amoxicillin clavulanate (875 mg + 125 mg per os three times a day for 5 days) vs. ceftazidime (1 g i.m., two times a day for 5 days) in postoperative period | In Group 1 (amoxicillin + clavulanic acid)—1 wound infection, 1 nausea, 1 headache, 1 diarrhea; In Group 2 (Ceftazidime)—1 heartburn |
| Duvall et al. [ | 2013 | RCT | 30 | Chlorhexidine 0.12% rinse vs. amoxicillin (2 g) vs. placebo before the surgery | There were no differences between groups in bacteremia. |
| Bortoluzzi et al. [ | 2013 | RCT | 50 | Group 1: 2 g of amoxicillin + 8 mg of dexamethasone; Group 2: 2 g of amoxicillin + 8 mg of placebo; Group 3: 8 mg of dexamethasone + 2 g of placebo and Group 4—placebo preoperative | 1—alveolar infection, 2 cases—alveolar osteitis. No differences were between postoperative complications. |
| Iglesias-Martin et al. [ | 2014 | RCT | 546 | Amoxicillin (1 g) vs. amoxicillin and clavunate (875/125 mg) postoperative | No differences between two groups. Group 1—patients with gastrointestinal complications. |
| Milani et al. [ | 2015 | RCT | 80 | Amoxicillin preoperative (1 group:1 h before surgery + 500 mg 8/8 h for 7 days; 2 group:1 h before surgery + 500 mg 8/8 h for 7 days) vs. placebo preoperative (1 h before surgery and 500 mg 8/8 h for 7 days) | There was no difference between groups. |
| Braimah et al. [ | 2017 | RCT | 135 | Amoxicillin with clavulanic acid (1 group: 1 gram preoperatively and then 625 mg for 5 days; 2 group: 1 g preoperatively only) vs. levofloxacin (1 g preoperatively only) | Quality of life (QoL) was assessed between 3 groups of different protocols of antibiotic treatment. There were differences between 3 groups. |
| Sidana et al. [ | 2017 | RCT | 400 | Group A: anti-inflammatory drugs in the postoperative period. Group B: Amoxicillin 500 mg orally thrice daily for three days + anti-inflammatory drugs in the postoperative period only. Group C: a single dose of Amoxicillin 500 mg one hour prior to the extraction procedure. Group D: mouthwash starting 15 min prior the procedure for a period of 7 days + anti-inflammatory drugs. | There was no difference between the groups to pain, swelling, or post extraction complications. |
| Mariscal-Cazalla et al. [ | 2021 | RCT | 92 | Group 1—750 mg amoxicillin before and after the surgery; Group 2 after surgery; Group 3 placebo before and after surgery. | Pain and inflammation were higher in group 3 than in groups 1 and 2. |
Figure 1Flow diagram describing the selection process according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations [17].
Risk of bias of randomized clinical trials, assessed through the ROB2 tool [28].
| Study | The Randomization Process | Deviations from the Intended Interventions | Missing Outcome Data | Measurement of Outcome Data | Selection of the Reported Result |
|---|---|---|---|---|---|
| Sisalli et al., 2012 [ | Some concerns | Some concerns | Low risk | Some concerns | Some concerns |
| Duvall et al., 2013 [ | Low risk | Low risk | Low risk | Low risk | Low risk |
| Milani et al., 2015 [ | Low risk | Low risk | Low risk | Low risk | Low risk |
| Braimah et al., 2017 [ | Low risk | Low risk | Low risk | Low risk | Low risk |
| Iglesias-Martin et al., 2014 [ | Some concerns | Some concerns | Low risk | Low risk | Low risk |
| López-Cedrún et al., 2011 [ | Low risk | Low risk | Low risk | Low risk | Low risk |
| Siddiqi et al., 2011 [ | Low risk | Low risk | Low risk | Low risk | Low risk |
| Sidana et al., 2017 [ | Low risk | Low risk | Low risk | Low risk | Low risk |
| Bortoluzzi et al., 2013 [ | Some concerns | Some concerns | Low risk | Low risk | Low risk |
| Mariscal-Cazalla et al., 2020 [ | Low risk | Low risk | Low risk | Low risk | Low risk |